Prosecution Insights
Last updated: April 19, 2026
Application No. 19/075,687

LOW PROFILE MEDICAL KIT

Non-Final OA §DP
Filed
Mar 10, 2025
Examiner
MUROMOTO JR, ROBERT H
Art Unit
3732
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Phokus Research Group LLC
OA Round
1 (Non-Final)
66%
Grant Probability
Favorable
1-2
OA Rounds
2y 4m
To Grant
56%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allow Rate
886 granted / 1332 resolved
-3.5% vs TC avg
Minimal -11% lift
Without
With
+-10.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 4m
Avg Prosecution
20 currently pending
Career history
1352
Total Applications
across all art units

Statute-Specific Performance

§101
2.4%
-37.6% vs TC avg
§103
40.1%
+0.1% vs TC avg
§102
31.8%
-8.2% vs TC avg
§112
16.8%
-23.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1332 resolved cases

Office Action

§DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Specification The abstract of the disclosure is objected to because the recitation “comprising” is claim type language not proper for US patent abstract practice. A corrected abstract of the disclosure is required and must be presented on a separate sheet, apart from any other text. See MPEP § 608.01(b). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-31 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-31 of U.S. Patent No. 12246646. Claims 1-31 are fully disclosed/anticipated by the patented claims. The MPEP 804.II.B.2 is clear: “A nonstatutory double patenting rejection is appropriate where a claim in an application under examination claims subject matter that is different, but not patentably distinct, from the subject matter claimed in a prior patent or a copending application. The claim under examination is not patentably distinct from the reference claim(s) if the claim under examination is anticipated by the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 1052, 29 USPQ2d 2010, 2015-16 (Fed. Cir. 1993). This type of nonstatutory double patenting situation arises when the claim being examined is, for example, generic to a species or sub-genus claimed in a conflicting patent or application, i.e., the entire scope of the reference claim falls within the scope of the examined claim. In such a situation, a later patent to a genus would, necessarily, extend the right to exclude granted by an earlier patent directed to a species or sub-genus. In this type of nonstatutory double patenting situation, an obviousness analysis is not required for the nonstatutory double patenting rejection… The species or sub-genus claimed in the conflicting patent or application anticipates the claimed genus in the application being examined and, therefore, a patent to the genus would improperly extend the right to exclude granted by a patent to the species or sub-genus should the genus issue as a patent after the species or sub-genus.”. Table below addresses the claims individually and how they correlate to the patented claim or claims. Instant claims Patented claims and any further statements to show anticipation 1 1; fully discloses new claim 1. 2 Verbatim to claim 2. 3 Verbatim to claim 3. 4 Verbatim to claim 4. 5 Verbatim to claim 5. 6 Verbatim to claim 6. 7 Verbatim to claim 7. 8 Near verbatim to claim 8 only changes nomenclature of “sealable pouch” to “casing”. A sealable pouch anticipates a casing. 9 Verbatim to claim 9. 10 Verbatim to claim 10. 11 Verbatim to claim 11. 12 Verbatim to claim 12. 13 Verbatim to claim 13. 14 Verbatim to claim 14. 15 15; fully discloses new claim 15. 16 Verbatim to claim 16. 17 Verbatim to claim 17. 18 Verbatim to claim 18. 19 Verbatim to claim 19. 20 Verbatim to claim 20. 21 Verbatim to claim 21. 22 Verbatim to claim 22. 23 Verbatim to claim 23. 24 Near verbatim to claim 24 only changes nomenclature of “sealable pouch” to “casing”. A sealable pouch anticipates a casing. 25 Verbatim to claim 25. 26 Verbatim to claim 26. 27 Verbatim to claim 27. 28 Verbatim to claim 28. 29 Verbatim to claim 29. 30 Claim 30 fully discloses new claim 30. 31 Claim 31 fully discloses new claim 31. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Various body armor and supply carrying vests are attached to establish the general state of the prior art. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ROBERT H MUROMOTO JR whose telephone number is (571)272-4991. The examiner can normally be reached M-Th 730-1730. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alissa Tompkins can be reached at 571-272-3425. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ROBERT H MUROMOTO JR/Primary Examiner, Art Unit 3732
Read full office action

Prosecution Timeline

Mar 10, 2025
Application Filed
Jan 08, 2026
Non-Final Rejection — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12588725
Visor Board For Use With Headgear Brim
2y 5m to grant Granted Mar 31, 2026
Patent 12582554
WELDING PROTECTION DEVICE WITH HAPTIC SENSING
2y 5m to grant Granted Mar 24, 2026
Patent 12569016
BODY ENERGY BALANCE ASSEMBLY EMPLOYING EARTH'S MAGNETIC FIELD AND ASSOCIATED METHODS
2y 5m to grant Granted Mar 10, 2026
Patent 12569018
DEVICES, METHOD AND KITS FOR REDUCING TRANSMISSION OF FECAL PATHOGENS
2y 5m to grant Granted Mar 10, 2026
Patent 12559871
SHEDDING MACHINE FOR A LOOM AND SHEDDING ASSEMBLY FOR A LOOM COMPRISING A GROUP OF SUCH MACHINES
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
66%
Grant Probability
56%
With Interview (-10.8%)
2y 4m
Median Time to Grant
Low
PTA Risk
Based on 1332 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month